ipamorelin mechanism of action and uses vs Sermorelin: Evidence & Clinical Guidance – PlexusDx CJC-1295 and Ipamorelin: Synergistic Peptides

Carrying groceries, climbing stairs, and other routine physical tasks require less effort and cause less fatigue

CJC-1295 (NO DAC) + Ipamorelin Peptide Blend Research & Scientific Overview Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References CJC-1295 (NO DAC) + Ipamorelin Peptide Blend Molecular Structure & Chemical Properties The CJC-1295 (NO DAC) + Ipamorelin peptide blend represents one of the most extensively studied growth hormone secretagogue combinations in preclinical research, with investigations spanning over two decades examining their synergistic effects on pituitary growth hormone release

Liang S, Hu Y, Liu C, et al

(NEJM 2007) documented a reduction in triglycerides of -50 mg/dL and an improvement in the total cholesterol/HDL ratio of -0.31 at 26 weeks of treatment

Neurochemical Research, 37(8), 1681-9